Actively Recruiting
Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease
Led by Genoss Co., Ltd. · Updated on 2025-02-21
1000
Participants Needed
1
Research Sites
332 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of study is to evaluate the efficacy and safety of short duration of DAPT after GENOSS® DES Implantation in patients with coronary artery disease.
CONDITIONS
Official Title
Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 19 years or older
- Patients with coronary artery disease treated with GENOSS sirolimus eluting stent (SES)
- Participants who voluntarily agree to participate, follow the study protocol and clinical follow-up plan, and provide written informed consent
You will not qualify if you...
- Patients with cardiogenic shock at the time of hospitalization
- Patients who are pregnant or planning to become pregnant
- Patients with a life expectancy of less than 1 year
- Patients participating in randomized controlled trials using other medical devices
- Patients who have already been treated with another drug-eluting stent (DES) or bare metal stent (BMS) at registration (except other stent insertion allowed if GENOSS DES insertion failed)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Wonju Severance Christian Hospital
Wŏnju, Gangwon State, South Korea
Actively Recruiting
Research Team
Y
YoungJin Youn
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here